1. Diet, microbiome, and colorectal cancer
    Sergey R. Konstantinov, 2017, Best Practice & Research Clinical Gastroenterology CrossRef
  2. A Review on Human Fecal Metabolomics: Methods, Applications and the Human Fecal Metabolome Database
    Naama Karu et al, 2018, Analytica Chimica Acta CrossRef
  3. Chronic ingestion of deoxynivalenol at human dietary levels impairs intestinal homeostasis and gut microbiota in mice
    Cécile Vignal et al, 2018, Arch Toxicol CrossRef
  4. Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer
    Huixun Jia et al, 2018, Radiotherapy and Oncology CrossRef
  5. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
    Sofie Bosch et al, 2018, J Cancer Res Clin Oncol CrossRef
  6. Gut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection
    Yong Qing et al, 2018, Dig Dis Sci CrossRef
  7. Navy Beans Impact the Stool Metabolome and Metabolic Pathways for Colon Health in Cancer Survivors
    Bridget Baxter et al, 2018, Nutrients CrossRef
  8. Nutritional Support After Surgery of the Colon
    Filippo Pucciani et al, 2019 CrossRef
  9. Metaproteomic and Metabolomic Approaches for Characterizing the Gut Microbiome
    Danielle L. Peters et al, 2019, Proteomics CrossRef
  10. Protective effect of the “food-microorganism-SCFAs” axis on colorectal cancer: from basic research to practical application
    Han Shuwen et al, 2019, J Cancer Res Clin Oncol CrossRef
  11. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
    Sunny H Wong et al, 2019, Nat Rev Gastroenterol Hepatol CrossRef
  12. Evaluation and comparison of short chain fatty acids composition in gut diseases
    Elena Niccolai et al, 2019, WJG CrossRef
  13. Akkermansia muciniphila is a new universal probiotic on the basis of live human commensal gut bacteria: the reality or legend?
    B. A. Shenderov et al, 2019, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii CrossRef
  14. Microbiome and Colorectal Cancer
    Ishfaq Ahmed et al, 2018, Curr Colorectal Cancer Rep CrossRef
  15. Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
    Samira Tarashi et al, 2019, Microorganisms CrossRef
  16. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    Kelly E van Keulen et al, 2020, Aliment Pharmacol Ther CrossRef
  17. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis
    Minsuk Kim et al, 2020, mBio CrossRef
  18. The interplay between dietary factors, gut microbiome and colorectal cancer: a new era of colorectal cancer prevention
    Poshita Kumari Seesaha et al, 2020, Future Oncology CrossRef
  19. Colorectal cancer diagnostic model utilizing metagenomic and metabolomic data of stool microbial extracellular vesicles
    Da Jung Kim et al, 2020, Sci Rep CrossRef
  20. Early detection and follow‐up of colorectal neoplasia based on faecal volatile organic compounds
    S. Bosch et al, 2020, Colorectal Dis CrossRef
  21. Bacterial association and comparison between lung and intestine in rats
    Tian-hao Liu et al, 2020 CrossRef
  22. Metabolite quantification of faecal extracts from colorectal cancer patients and healthy controls
    Gwénaëlle Le Gall et al, 2018, Oncotarget CrossRef
  23. Functional Roles of B‐Vitamins in the Gut and Gut Microbiome
    Takashi Uebanso et al, 2020, Mol. Nutr. Food Res. CrossRef
  24. WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11
    Shuqin Xing et al, 2020 CrossRef

  25. Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites


    Shuwen Han et al, 2020, CMAR CrossRef
  26. A Review of GC-Based Analysis of Non-Invasive Biomarkers of Colorectal Cancer and Related Pathways
    Fernanda Monedeiro et al, 2020, JCM CrossRef
  27. An analysis of gut dysbiosis in obesity, diabetes, and chronic gut conditions
    Ahmed Haleem et al, 2020, Ibnosina J Med Biomed Sci CrossRef
  28. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk.
    Elizabeth L Barry et al, 2020, Cancer Prev Res (Phila) CrossRef
  29. Stem Cell Impairment at the Host-Microbiota Interface in Colorectal Cancer
    Marinella Marzano et al, 2021, Cancers CrossRef
  30. Gut Microbes in Gastrointestinal Cancers
    Fei Wang et al, 2021, Seminars in Cancer Biology CrossRef
  31. Towards Novel Non-Invasive Colorectal Cancer Screening Methods: A Comprehensive Review
    Allegra Ferrari et al, 2021, Cancers CrossRef
  32. Integrated approaches for precision oncology in colorectal cancer: The more you know, the better.
    Pietro Andrei et al, 2022, Semin Cancer Biol CrossRef
  33. A literature survey of all volatiles from healthy human breath and bodily fluids: the human volatilome
    Natalia Drabińska et al, 2021, J. Breath Res. CrossRef
  34. Short-Chain Fatty Acids as Therapeutic Agents in Colon Malignancies
    Arundhati Mehta et al, 2021 CrossRef
  35. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome
    Bani Ahluwalia et al, 2021, Cells CrossRef
  36. Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers
    Chuan-Yin Fang et al, 2021, Microorganisms CrossRef
  37. Odors and cancer: Current status and future directions.
    Flora Gouzerh et al, 2022, Biochim Biophys Acta Rev Cancer CrossRef
  38. Simultaneous quantification of eleven short-chain fatty acids by derivatization and solid phase microextraction - gas chromatography tandem mass spectrometry
    Zhibo Fu et al, 2021, Journal of Chromatography A CrossRef
  39. Research Progress of Physiological Function of Short-Chain Fatty Acids in the Intestine
    桐 殷, 2022, ACM CrossRef
  40. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Olabisi Oluwabukola Coker et al, 2022, Microbiome CrossRef
  41. The potential of fecal microbiota and amino acids to detect and monitor patients with adenoma
    Sofie Bosch et al, 2022, Gut Microbes CrossRef
  42. A systematic review of microbial markers for risk prediction of colorectal neoplasia
    Lili Yu et al, 2022, Br J Cancer CrossRef
  43. Branched Short-Chain Fatty Acids as Biological Indicators of Microbiota Health and Links with Anthropometry
    Nuria Salazar et al, 2022 CrossRef
  44. A dynamic multiple reaction monitoring strategy to develop and optimize targeted metabolomics methods: analyzing bile acids in capecitabine-induced diarrhea
    Zhipeng Wang et al, 2022, Journal of Pharmaceutical and Biomedical Analysis CrossRef
  45. Assessment of the Human Metabolome as a Method for Molecular Diagnostics of Colorectal Cancer: Prevention and Therapy
    G. A. Shilovsky et al, 2022, Biol Bull Rev CrossRef
  46. Healthy gut microbiome in the prevention of colorectal cancer
    Marufa Rumman et al, 2022 CrossRef
  47. Plasma Metabolomics Analysis of Aspirin Treatment and Risk of Colorectal Adenomas
    Elizabeth L. Barry et al, 2022 CrossRef
  48. Fecal metabolomics reveals the positive effect of ethanol extract of propolis on T2DM mice
    Chunmei Wang et al, 2023, Food Science and Human Wellness CrossRef
  49. Establishment of an early diagnosis model of colon cancerous bowel obstruction based on 1H NMR
    Jie Zeng et al, 2022, PLoS ONE CrossRef
  50. Intestinal microbiota regulates diabetes and cancer progression by IL-1β and NOX4 dependent signaling cascades
    Mohamed Noureldein et al, 2022, Cell. Mol. Life Sci. CrossRef
  51. Untargeted ultra-high-resolution mass spectrometry metabolomic profiling of blood serum in bladder cancer
    Joanna Nizioł et al, 2022, Sci Rep CrossRef
  52. Low-dose radiation exaggerates HFD-induced metabolic dysfunction by gut microbiota through PA-PYCR1 axis
    Zhao Ju et al, 2022, Commun Biol CrossRef
  53. Short-chain fatty acid concentrations in the incidence and risk-stratification of colorectal cancer: a systematic review and meta-analysis
    Ehsan Alvandi et al, 2022, BMC Med CrossRef
  54. Branched Short-Chain Fatty Acids as Biological Indicators of Microbiota Health and Links with Anthropometry
    Nuria Salazar et al, 2022 CrossRef
  55. A pre‐column derivatization high‐performance liquid chromatography method for simultaneous determination of short‐chain and medium‐chain fatty acids in a fecal sample
    Zhibo Fu et al, 2022, J of Separation Science CrossRef
  56. Metagenomics and metabolomics analysis to investigate the effect of Shugan decoction on intestinal microbiota in irritable bowel syndrome rats
    Lu Hang et al, 2022, Front. Microbiol. CrossRef
  57. Gut microbial metabolites and colorectal cancer
    Muqaddas Masood et al, 2023 CrossRef
  58. Akkermansia muciniphila plays critical roles in host health
    Qixiang Zhao et al, 2023, Critical Reviews in Microbiology CrossRef
  59. A Novel Non-Invasive Colorectal Cancer Diagnostic Method: Volatile Organic Compounds As Biomarkers
    Miren Alustiza et al, 2023, Clinica Chimica Acta CrossRef
  60. Review on microbial metabolomics of probiotics and pathogens: Methodologies and applications
    XIN MENG et al, 2023 CrossRef
  61. A Dynamic Multiple Reaction Monitoring Strategy to Develop and Optimize Targeted Metabolomics Methods: An Example of Analyzing Bile Acids and its Application in Capecitabine-Induced Diarrhea
    Zhipeng Wang et al, 2022, SSRN Journal CrossRef
  62. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
    Ruize Qu et al, 2023, Adv Sci (Weinh) CrossRef
  63. Gut Microbiota and Colorectal Cancer Risk Factors
    Hadi Feizi et al, 2023, CPB CrossRef
  64. Microbial-Related Metabolites May Be Involved in Eight Major Biological Processes and Represent Potential Diagnostic Markers in Gastric Cancer
    Siru Nie et al, 2023, Cancers CrossRef
  65. Origin and Emission of Volatile Biomarkers from Feces
    R. Slater et al, 2022 CrossRef
  66. Gut microbial metabolites: shaping future diagnosis and treatment against gastrointestinal cancer
    Hongyan Gou et al, 2024, Pharmacological Research CrossRef
  67. Advances in multi-omics integrated analysis methods based on the gut microbiome and their applications
    Dongdong Duan et al, 2025, Front. Microbiol. CrossRef
  68. RGCGT: A high-order feature learning framework for predicting disease-metabolite interaction using residual graph convolution and graph transformer
    Wenzhi Liu et al, 2025, Expert Systems with Applications CrossRef